Roxadustat for muscle loss in dialysis patients
Treatments studied
Part of Blood & lymphatic, Brain & nervous system clinical trials.
This trial tests whether a drug called roxadustat (taken as a pill) can help people on dialysis who also have sarcopenia (loss of muscle strength and mass). It aims to see if the drug improves muscle health and anemia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You need to have been on kidney dialysis for at least 16 weeks.
- Your hemoglobin (red blood cell count) should be between 7.0 and 10.0 g/dL.
- You must not have taken ESAs or roxadustat recently.
- You must have a diagnosis of sarcopenia (low muscle strength and low muscle mass).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for adults with chronic kidney disease and low muscle strength (sarcopenia). It aims to find ways to improve outcomes, especially if you have a higher risk of complications.
This study looks at a possible nutritional supplement (valine) to help people with advanced chronic kidney disease who also have muscle weakness (sarcopenia). It will test whether the supplement can improve muscle strength and function.
This study tests whether exercise during hemodialysis can improve muscle oxygen levels and how well dialysis works. It is for people who have been on dialysis for at least a year and have muscle loss (sarcopenia).
This study looks at whether a simple blood test can help measure muscle loss in people on dialysis. If you join, researchers will check your blood levels and see how they relate to your muscle strength and function, which might help improve care for people with kidney failure.
This study tests whether a medicine called Ketosteril can improve muscle strength and function in people with moderate to severe chronic kidney disease (CKD) who also have sarcopenia (age-related muscle loss).
This trial tests if a supervised exercise program can help people on dialysis who have muscle wasting (uremic sarcopenia). It aims to improve muscle strength, physical function, and quality of life.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.